| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |